Generic Drug Pricing: Actionable Research for Policy

This project has four aims:
1. Describe price increases in generics over the last decade, both by molecule and therapeutic class.
2. Identify the correlates of generic price increases and undertake multivariate analysis to unravel the causes of these increases.
3. Quantify the financial burden of price increases on patients and payers.
4. Propose policy options based on the findings and quantify their potential impact.
For this research, the project team will draw from IMS Health Incorporated’s National Sales Perspectives database summarizing drugs, manufacturers, and prices during the last decade.

The results will shed light on the fundamental dynamics of the generic drug market and aid the design of evidence-based policies to improve competition, control price increases, and help predict where future “pricing hotspots” will arise.